As health becomes the number one issue, politically, socially, economically, and personally, there is nothing on the current horizon of products or services available in the USA Healthcare (Sickcare) system that looks like it can alleviate the quagmire we as US citizens are currently stuck with.
It will become obvious the most important and underserved player in this 3 party system is the 1st party—the individual or “Health Consumer”. To this end the measurement and assessment of the individual for pre-disease states and genomic testing is the most untapped resource. Driven by cost, risk, intervention, worried well, anti-aging or higher quality of life, the many “Healthy” consumers are looking for a consumer friendly interface into medical science. Fueled by exponential growth of genomics, biology, and digital networks like the internet, the management of a WellCare state for the individual is a complete new market or “Value Chain” that introduces the need for Consumer Driven Testing (CDT), either for monitoring states of health or looking for maximizing Health potential.
This Wellcare industry is already flourishing, with many companies having been in CDT for years and now with the internet it is growing dramatically .
“The macroeconomics of our entire economy
has changed in the last 15 years, and the
macroeconomics of medicine will change as well.”